Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Adachi

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Viruses|April 23, 2022
Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without FavipiravirKanako Shinada, Takashi Sato, Saya Moriyama, et al.
Cell Host & Microbe|May 21, 2019
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral EpitopeGoran Bajic, Max J Maron, Yu Adachi, et al.
Iscience|August 22, 2022
SARS-CoV-2-specific CD4<sup>+</sup> T cell longevity correlates with Th17-like phenotypeKazutaka Terahara, Takashi Sato, Yu Adachi, et al.
Nature Communications|June 19, 2021
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cellsKosuke Miyauchi, Yu Adachi, Keisuke Tonouchi, et al.
NPJ Vaccines|April 25, 2026
Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopesShintaro Oishi, Ryutaro Kotaki, Hisham M Dokainish, et al.
Nature Communications|March 16, 2023
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domainTomohiro Takano, Takashi Sato, Ryutaro Kotaki, et al.
Mbio|May 20, 2025
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interfaceHolly C Simmons, Joel Finney, Ryutaro Kotaki, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interfaceHolly C Simmons, Joel Finney, Ryutaro Kotaki, et al.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
Science Translational Medicine|August 21, 2024
Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution toward the latest variantsRyutaro Kotaki, Saya Moriyama, Shintaro Oishi, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Viruses|April 23, 2022
Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without FavipiravirKanako Shinada, Takashi Sato, Saya Moriyama, et al.
Cell Host & Microbe|May 21, 2019
Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral EpitopeGoran Bajic, Max J Maron, Yu Adachi, et al.
Iscience|August 22, 2022
SARS-CoV-2-specific CD4<sup>+</sup> T cell longevity correlates with Th17-like phenotypeKazutaka Terahara, Takashi Sato, Yu Adachi, et al.
Nature Communications|June 19, 2021
Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cellsKosuke Miyauchi, Yu Adachi, Keisuke Tonouchi, et al.
NPJ Vaccines|April 25, 2026
Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopesShintaro Oishi, Ryutaro Kotaki, Hisham M Dokainish, et al.
Nature Communications|March 16, 2023
Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domainTomohiro Takano, Takashi Sato, Ryutaro Kotaki, et al.
Mbio|May 20, 2025
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interfaceHolly C Simmons, Joel Finney, Ryutaro Kotaki, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interfaceHolly C Simmons, Joel Finney, Ryutaro Kotaki, et al.
Cell Reports. Medicine|May 11, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccineTomohiro Takano, Miwa Morikawa, Yu Adachi, et al.
Science Translational Medicine|August 21, 2024
Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution toward the latest variantsRyutaro Kotaki, Saya Moriyama, Shintaro Oishi, et al.
Pageof 5